{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:08:19Z","timestamp":1772046499198,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2026,2,17]]},"DOI":"10.1136\/ejhpharm-2025-004695","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:20:25Z","timestamp":1772043625000},"page":"ejhpharm-2025-004695","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of residual stainless steel surface contamination in an anticancer drug preparation microbiological safety cabinet after decontamination with four cleaning solutions"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7757-8993","authenticated-orcid":false,"given":"Joshua","family":"Convert","sequence":"first","affiliation":[{"name":"Clinical Oncology Pharmacy Unit, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Guitton","sequence":"additional","affiliation":[{"name":"Biochemistry and Toxicology Laboratory, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"},{"name":"Toxicology Laboratory, Universit\u00e9 Claude Bernard Lyon 1 Institut des Sciences Pharmaceutiques et Biologiques Facult\u00e9 de Pharmacie de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Ranchon","sequence":"additional","affiliation":[{"name":"Clinical Oncology Pharmacy Unit, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"},{"name":"CICLY - EA 3738, Oullins-Pierre-B\u00e9nite, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Cerutti","sequence":"additional","affiliation":[{"name":"Clinical Oncology Pharmacy Unit, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Herledan","sequence":"additional","affiliation":[{"name":"Clinical Oncology Pharmacy Unit, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"},{"name":"CICLY - EA 3738, Oullins-Pierre-B\u00e9nite, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-0673","authenticated-orcid":false,"given":"Frederic","family":"Lagarce","sequence":"additional","affiliation":[{"name":"Pharmacy, Centre Hospitalier Universitaire d\u2019Angers, Angers, France"},{"name":"INSERM 1066, Angers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Rioufol","sequence":"additional","affiliation":[{"name":"Clinical Oncology Pharmacy Unit, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"},{"name":"CICLY - EA 3738, Oullins-Pierre-B\u00e9nite, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vantard","sequence":"additional","affiliation":[{"name":"Clinical Oncology Pharmacy Unit, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026022510201277000_ejhpharm-2025-004695v1.1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155207082350"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.2","unstructured":"European Commission, Directorate General for Employment, Social Affairs and Inclusion . Guidance for the safe management of hazardous medicinal products at work. 2023. Available: https:\/\/employment-social-affairs.ec.europa.eu\/guidance-safe-management-hazardous-medicinal-products-work_en"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.3","unstructured":"United States Pharmacopeial Convention 800 . Hazardous drugs\u2014handling in healthcare settings. Available: https:\/\/www.usp.org\/compounding\/general-chapter-hazardous-drugs-handling-healthcare"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235131","article-title":"Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces","volume":"15","author":"Simon","year":"2020","journal-title":"PLoS One"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002440"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.6","doi-asserted-by":"publisher","DOI":"10.1191\/1078155203jp102oa"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-004-0595-1"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.8","first-page":"185","article-title":"Risques reprotoxiques et exposition professionnelle aux anticanc\u00e9reux en milieu hospitalier: approche par l\u2019analyse multivari\u00e9e","volume":"21","author":"Tigha-Bouaziz","year":"2019","journal-title":"M\u00e9decine Reprod"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1177\/1078155220907129","article-title":"Quantification of healthcare workers\u2019 exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study","volume":"26","author":"Palamini","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/10781552241285138","article-title":"Workflow evaluation of environmental contamination with hazardous drugs during compounding and administration in an UK hospital","volume":"32","author":"Sessink","year":"2026","journal-title":"J Oncol Pharm Pract"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.11","doi-asserted-by":"crossref","DOI":"10.1097\/OP9.0000000000000024","article-title":"Environmental contamination with cytotoxic drugs in 15 hospitals from 11 European countries\u2014results of the MASHA project","volume":"3","author":"Korczowska","year":"2020","journal-title":"Eur J Oncol Pharm"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.12","first-page":"20190017","article-title":"Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units","volume":"5","author":"Palamini","year":"2020","journal-title":"Pharm Technol Hosp Pharm"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12302-021-00544-5","article-title":"Levels and risks of antineoplastic drugs in households of oncology patients, hospices and retirement homes","volume":"33","author":"Bl\u00e1hov\u00e1","year":"2021","journal-title":"Environ Sci Eur"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.14","unstructured":"National Institute for Occupational Safety and Health (NIOSH) . Preventing occupational exposure to antineoplastic and other hazardous drugs in healthcare settings. Cincinnati NIOSH; 2004. Available: http:\/\/cdc.gov\/niosh\/docs\/2004-165\/"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00420-021-01679-x","article-title":"Evaluation of a safe infusion device on reducing occupational exposure of nurses to antineoplastic drugs: a comparative prospective study. Contamoins-1","volume":"94","author":"Forges","year":"2021","journal-title":"Int Arch Occup Environ Health"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159052","article-title":"Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study","volume":"11","author":"Simon","year":"2016","journal-title":"PLoS One"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.17","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/mes087"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/mev031"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15459624.2018.1526384","article-title":"Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system","volume":"16","author":"Federici","year":"2019","journal-title":"J Occup Environ Hyg"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/15459624.2015.1009985","article-title":"Cleaning Efficiencies of Three Cleaning Agents on Four Different Surfaces after Contamination by Gemcitabine and 5-fluorouracile","volume":"12","author":"B\u00f6hlandt","year":"2015","journal-title":"J Occup Environ Hyg"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/1078155219831427","article-title":"Efficiency of degradation or desorption methods in antineoplastic drug decontamination: A critical review","volume":"25","author":"Simon","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4212\/cjhp.v70i6.1708","article-title":"Comparison of Decontamination Efficacy of Cleaning Solutions on a Biological Safety Cabinet Workbench Contaminated by Cyclophosphamide","volume":"70","author":"Ad\u00e9","year":"2017","journal-title":"Can J Hosp Pharm"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1051\/ata:2007003","article-title":"Utilisation de l\u2019ICP-MS en biologie clinique","volume":"19","author":"M\u0153sch","year":"2007","journal-title":"Ann Toxicol Anal"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.24","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/mei045"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.25","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1021\/acs.est.2c08244","article-title":"Quaternary Ammonium Compounds: A Chemical Class of Emerging Concern","volume":"57","author":"Arnold","year":"2023","journal-title":"Environ Sci Technol"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15459624.2020.1854458","article-title":"Evaluation of decontamination efficacy of four antineoplastics (ifosfamide, 5-fluorouracil, irinotecan, and methotrexate) after deliberate contamination","volume":"18","author":"Palamini","year":"2021","journal-title":"J Occup Environ Hyg"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.27","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1177\/1078155220915961","article-title":"Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unit","volume":"26","author":"Petit","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.28","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/dta.3902","article-title":"Surface Wipe Sampling of Hazardous Medicinal Products: A European Interlaboratory Comparison Study","volume":"17","author":"van den Berg","year":"2025","journal-title":"Drug Test Anal"},{"key":"2026022510201277000_ejhpharm-2025-004695v1.29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/10781552241307905","article-title":"Cytotoxic surface contamination in hospitals: Current practices, challenges and perspectives","volume":"31","author":"Favier","year":"2025","journal-title":"J Oncol Pharm Pract"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:20:31Z","timestamp":1772043631000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":29,"alternative-id":["10.1136\/ejhpharm-2025-004695"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004695","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}